These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 11375781)

  • 21. Cytochrome P450s and other enzymes in drug metabolism and toxicity.
    Guengerich FP
    AAPS J; 2006 Mar; 8(1):E101-11. PubMed ID: 16584116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enzymatic activation of chemicals to toxic metabolites.
    Guengerich FP; Liebler DC
    Crit Rev Toxicol; 1985; 14(3):259-307. PubMed ID: 3926381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Transplacental teratogenesis].
    Grella PV
    Acta Biomed Ateneo Parmense; 2000; 71 Suppl 1():467-72. PubMed ID: 11424790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of Drugs and other Xenobiotics as Key Modulator of Toxicity.
    Orhan H
    Curr Drug Metab; 2021; 22(8):582-583. PubMed ID: 34636292
    [No Abstract]   [Full Text] [Related]  

  • 25. Many drugs and phytochemicals can be activated to biological reactive intermediates.
    Johnson WW
    Curr Drug Metab; 2008 May; 9(4):344-51. PubMed ID: 18473753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel advances in biotransformation and bioactivation research-2019 year in review
    Khojasteh SC; Driscoll JP; Jackson KD; Miller GP; Mitra K; Rietjens IMCM; Zhang D
    Drug Metab Rev; 2020 Aug; 52(3):333-365. PubMed ID: 32645275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphism in drug metabolism--implications for drug toxicity.
    Smith RL
    Arch Toxicol Suppl; 1986; 9():138-46. PubMed ID: 3468894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor- and reactive intermediate-mediated mechanisms of teratogenesis.
    Wells PG; Lee CJ; McCallum GP; Perstin J; Harper PA
    Handb Exp Pharmacol; 2010; (196):131-62. PubMed ID: 20020262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective.
    Tang W; Lu AY
    Drug Metab Rev; 2010 May; 42(2):225-49. PubMed ID: 19939207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of bioactivation in drug-induced hypersensitivity reactions.
    Sanderson JP; Naisbitt DJ; Park BK
    AAPS J; 2006 Feb; 8(1):E55-64. PubMed ID: 16584134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Progress report. Possibilities and limitations of the in vitro technic for prenatal toxicologic studies].
    Bleyl DW
    Nahrung; 1984; 28(10):1053-63. PubMed ID: 6513999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical toxicology of reactive intermediates formed by the glutathione-dependent bioactivation of halogen-containing compounds.
    Anders MW
    Chem Res Toxicol; 2008 Jan; 21(1):145-59. PubMed ID: 17696489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II enzymes and bioactivation.
    Hinson JA; Forkert PG
    Can J Physiol Pharmacol; 1995 Oct; 73(10):1407-13. PubMed ID: 8748931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are chemically reactive metabolites responsible for adverse reactions to drugs?
    Williams DP; Kitteringham NR; Naisbitt DJ; Pirmohamed M; Smith DA; Park BK
    Curr Drug Metab; 2002 Aug; 3(4):351-66. PubMed ID: 12093355
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics, pharmacodynamics, and prediction of developmental abnormalities.
    O'Flaherty EJ
    Reprod Toxicol; 1997; 11(2-3):413-6. PubMed ID: 9100316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential molecular targets mediating chemical teratogenesis: in vitro peroxidase-catalyzed phenytoin metabolism and oxidative damage to proteins and lipids in murine maternal hepatic microsomes and embryonic 9000g supernatant.
    Liu L; Wells PG
    Toxicol Appl Pharmacol; 1995 Sep; 134(1):71-80. PubMed ID: 7676459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Environmental contaminants in pathogenesis of breast cancer.
    Mukherjee S; Koner BC; Ray S; Ray A
    Indian J Exp Biol; 2006 Aug; 44(8):597-617. PubMed ID: 16924830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoxygenase--a versatile biocatalyst for biotransformation of endobiotics and xenobiotics.
    Kulkarni AP
    Cell Mol Life Sci; 2001 Nov; 58(12-13):1805-25. PubMed ID: 11766881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of all-trans-retinol and all-trans-retinal to all-trans-retinoic acid in rat conceptal homogenates.
    Chen H; Namkung MJ; Juchau MR
    Biochem Pharmacol; 1995 Oct; 50(8):1257-64. PubMed ID: 7488242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
    Brent RL
    Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.